Louis Fabri

3.3k total citations
55 papers, 2.6k citations indexed

About

Louis Fabri is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Louis Fabri has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Oncology. Recurrent topics in Louis Fabri's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Glycosylation and Glycoproteins Research (9 papers). Louis Fabri is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Glycosylation and Glycoproteins Research (9 papers). Louis Fabri collaborates with scholars based in Australia, United States and Sweden. Louis Fabri's co-authors include Andrew D. Nash, Douglas J. Hilton, Nicos A. Nicola, Edouard C. Nice, Tracy A. Willson, Manuel Baca, Donald Metcalf, David P. De Souza, Jian‐Guo Zhang and Antony W. Burgess and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Louis Fabri

55 papers receiving 2.6k citations

Peers

Louis Fabri

ONCOL

IMMUN

RNMI

EDM

Siegfried Stengelin Germany

Brent L. Kreider United States

Thomas F. Bumol United States

Diane Watling United Kingdom

Paul S. Changelian United States

Giovanna Barbieri Italy

Yannick Jacques France

Martin Hegen United States

Barbara J. Brandhuber United States

Jinzhao Hou United States

Siegfried Stengelin Germany

Louis Fabri

1.3k ×0.9

680 ×0.6

ONCOL

813 ×1.1

IMMUN

377 ×1.2

RNMI

150 ×0.7

EDM

Citations per year, relative to Louis Fabri Louis Fabri (= 1×) peers Siegfried Stengelin

Countries citing papers authored by Louis Fabri

Since Specialization

Citations

This map shows the geographic impact of Louis Fabri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Fabri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Fabri more than expected).

Fields of papers citing papers by Louis Fabri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Fabri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Fabri. The network helps show where Louis Fabri may publish in the future.

Co-authorship network of co-authors of Louis Fabri

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Fabri. A scholar is included among the top collaborators of Louis Fabri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Fabri. Louis Fabri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Irene, et al.. (2024). Application of mechanistic modelling in membrane and fiber chromatography for purification of biotherapeutics — A review. Journal of Chromatography A. 1716. 464588–464588. 6 indexed citations

Chen, Shih-Hsun, et al.. (2023). Scalability of Sartobind® Rapid A Membrane for High Productivity Monoclonal Antibody Capture. Membranes. 13(10). 815–815. 5 indexed citations

Bekard, Innocent B., et al.. (2023). Economic optimization of antibody capture through Protein A affinity nanofiber chromatography. Biochemical Engineering Journal. 201. 109141–109141. 4 indexed citations

Fabri, Louis, et al.. (2020). The Reasonable and Conscious Understanding System of reality Under Uncertainty. International Journal of Circuits Systems and Signal Processing. 14. 3 indexed citations

Butcher, R.E., Catherine M. Owczarek, Matthew P. Hardy, et al.. (2019). Optimizing high throughput antibody purification by using continuous chromatography media. Protein Expression and Purification. 159. 75–82. 4 indexed citations

Boo, Irene, Jun Gu, Kathleen McCaffrey, et al.. (2016). The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs. Hepatology. 65(4). 1117–1131. 56 indexed citations

Schmidt, Péter, R.E. Butcher, Pierre Scotney, et al.. (2016). A robust robotic high-throughput antibody purification platform. Journal of Chromatography A. 1455. 9–19. 22 indexed citations

Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2014). Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia. 28(11). 2213–2221. 106 indexed citations

Schaub, Alexander, Miriam Ender, Marc W. Nolte, et al.. (2013). Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro. PLoS ONE. 8(5). e63162–e63162. 8 indexed citations

10.

Munro, Kathryn M., Kirsty J. Dixon, Melissa Gresle, et al.. (2013). EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE). PLoS ONE. 8(2). e55948–e55948. 23 indexed citations

11.

Leonard, Philip M., Pierre Scotney, T. Jabeen, et al.. (2008). Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralising Antibody Fab Fragment. Journal of Molecular Biology. 384(5). 1203–1217. 13 indexed citations

12.

Greenhalgh, Christopher J., Donald Metcalf, Anne L. Thaus, et al.. (2002). Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling. Journal of Biological Chemistry. 277(43). 40181–40184. 143 indexed citations

13.

Nice, E.C., Teresa Domagała, Louis Fabri, et al.. (2002). Rapid Microscale Enzymic Semisynthesis of Epidermal Growth Factor (EGF) Analogues. Growth Factors. 20(2). 71–80. 4 indexed citations

14.

Moritz, Robert L., et al.. (1999). The N-Terminus of gp130 is Critical for the Formation of the High-Affinity Interleukin-6 Receptor Complex. Growth Factors. 16(4). 265–278. 23 indexed citations

15.

Alexander, Warren S., Steven Rakar, Lorraine Robb, et al.. (1999). Suckling defect in mice lacking the soluble haemopoietin receptor NR6. Current Biology. 9(11). 605–S1. 67 indexed citations

16.

Nice, Edouard C., Louis Fabri, Annet Hammacher, K. Andersson, & Ulf Hellman. (1993). Micropreparative ion exchange high performance liquid chromatography: Applications to microsequence analysis. Biomedical Chromatography. 7(2). 104–111. 7 indexed citations

17.

Fabri, Louis, et al.. (1992). Characterization of bovine heparin-binding neurotrophic factor (HBNF): assignment of disulfide bonds.. PubMed. 28(1). 1–9. 11 indexed citations

18.

Nice, Edouard C., Peter J. Dempsey, Judith E. Layton, et al.. (1990). Human Granulocyte-Macrophage Colony-Stimulating Factor (hGM-CSF): Identification of a Binding Site for a Neutralizing Antibody. Growth Factors. 3(2). 159–169. 19 indexed citations

19.

Lloyd, Chris J., Edouard G. Stanley, Francesca Walker, et al.. (1988). Murine epidermal growth factor: structure and function. Biochemistry. 27(14). 4977–4985. 47 indexed citations

20.

Fabri, Louis, et al.. (1987). Comparison of iodinated [Nle¹⁵]‐ and [Met¹⁵]‐gastrin₁₇ prepared by reversed‐phase HPLC. Biomedical Chromatography. 2(4). 159–163. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact